Research – Policy & Medicine

Unlocking the Fatty Liver Mistry: The Silent Threat of Fatty Liver Disease Unveiled

Maine Finalizes Its Physician “Gift Ban” Rules Updates to $500 limit Includes Exemptions for Pharmacists, Speaker Fees, Expenses, Accredited Education and Market Research

OPDP to Study Physicians’ Interpretations of Drug Information

Duke Agrees to Pay $112.5 Million in False Claims Act Settlement Related to Scientific Research Misconduct

FDA Publishes List of Drug Companies Allegedly Blocking Access to Drug Samples

Numerof & Associates Releases Annual Report on Health Adoption

New Research Published on Generic Competition

US Senate Passes FDA User Fees, Right to Try and Opioid Legislation

PhRMA Report Shows More than 240 Immuno-Oncology Treatments in Development

FDA Drug Approvals on an Uptick